Executive Summary

Valued at 253.2 USD Million in 2025, the Nicotinamide Market is forecast to reach 535.5 USD Million by 2035, expanding at a CAGR of 7.78%.

Two forces anchor demand: the EU’s 2024 renewal of niacinamide as a feed additive through 2034 (Regulation (EU) 2024/1194), and dermocosmetic brands formulating to USP, BP/EP, and JP grades for barrier-repair and brightening claims.

Skin Care leads end use with a 10.4% share, as formulation moves from bulk fortification toward barrier-repair skincare. Asia Pacific, North America, and Europe stand out as the market’s principal growth regions.

Producer pricing stayed volatile after Chinese environmental inspections tightened export availability through Q2 2026, following an oversupply-driven price decline in late 2025. Supply remains fragmented, with grade specification and distribution reach the deciding competitive factors.

Key Takeaways

• A CAGR of 7.78% carries the market from USD 253.20 Million in 2025 to USD 535.50 Million in 2035.
• Skin Care leads on end use application, at 10.4% of 2025 revenue.
• Pharmaceutical / USP Grade is the largest grade category.
• 11 suppliers are profiled, in a fragmented market.

Market Definition and Scope

The Nicotinamide Market covers vitamin B3 material supplied as pharmaceutical/USP, cosmetic, food, feed, and industrial/technical grade, across powder, granule, liquid, gel, emulsion, and paste forms, sold into dermocosmetic, dietary-supplement, food-fortification, animal-feed-premix, and industrial-intermediate applications from formulators through to OEM and distributor channels.

Nicotinic acid, the related free-acid vitamer regulated separately under additive 3a314, sits outside this boundary, as do shark-liver-oil-derived squalene actives, a distinct cosmetic ingredient chemistry with no nicotinamide content.

Market Trends

Dermocosmetic brands are shifting niacinamide from bulk fortificant to barrier-repair active

Skin Care leads end-use demand at a 10.4% share, and formulators are moving niacinamide from bulk multivitamin fortification into barrier-repair serums, brightening treatments, and pharmacy-channel dermocosmetic lines that specify USP, BP/EP, or JP pharmacopeial purity. The shift concentrates value in micronized cosmetic-grade and pharmaceutical-grade material rather than in additional tonnage, favoring suppliers that can certify pharmacopeial compliance over those competing on price alone.

Chinese environmental enforcement has become the swing variable in global supply

Environmental inspections in China tightened export availability in the second quarter of 2026, pushing Chinese price assessments up 21.74% quarter-on-quarter and Indian assessments up 15.6% as import premiums narrowed. Because Chinese producers set the marginal ton, importing formulators in the US, Germany, and South Korea now price against enforcement cycles rather than downstream demand, adding volatility to procurement planning through the forecast period.

The EU’s ten-year feed-additive renewal is locking in compound-feed volume

The European Commission renewed niacinamide’s authorisation as a feed additive for all animal species in April 2024, fixing a minimum 99% purity specification and extending eligibility to 15 May 2034. The ten-year horizon gives feed-grade producers unusual demand visibility in a market otherwise exposed to price swings, and it sets the purity bar that feed-grade suppliers must certify against through the forecast period.

Growth Drivers and Restraints

EU’s ten-year feed-additive renewal locks in compound-feed offtake

The European Commission’s April 2024 renewal of niacinamide as a feed additive, Regulation (EU) 2024/1194, repeals the prior 2013 authorization (Regulation (EU) No 642/2013) and fixes a minimum 99% purity specification (CAS 98-92-0) valid through 15 May 2034. Compound-feed producers supplying food-producing and non-food-producing animal segments absorb the transition, with feed-grade material required to certify against the new purity threshold as legacy-batch sell-through windows close through May 2026.

Pharmacopeial compliance is widening the premium dermocosmetic channel

Formulators certifying material to US, European, and Japanese pharmacopeial monographs (USP, BP/EP, JP) can move niacinamide directly into prescription-adjacent dermocosmetic lines sold through pharmacy channels, the category tracked in the grade axis as Dermocosmetic/Professional Care. Skin Care already leads end-use demand at a 10.4% share; brands citing pharmacopeial-grade sourcing on-pack capture premium pricing that cosmetic-grade-only suppliers cannot match, pulling formulator sourcing toward pharmaceutical/USP-grade material even for topical, non-ingested applications.

Food and feed fortification standards are broadening the addressable grade mix

Food-grade niacinamide sold for cereal and beverage fortification must certify to Food Chemicals Codex (FCC) or JECFA specifications, standards distinct from the feed-grade and pharmaceutical monographs governing other channels. That separation lets producers run parallel qualification tracks rather than a single blended spec, and it is pulling food-grade volume into national fortification programs that reference JECFA acceptable-daily-intake determinations for vitamin B3.

Enforcement-driven supply swings raise inventory risk for importing formulators

Environmental inspections in China tightened export availability in the second quarter of 2026, lifting Chinese price assessments 21.74% quarter-on-quarter and Indian assessments 15.6% as import premiums narrowed. Because China supplies the marginal ton, importing formulators outside Asia carry inventory risk tied to enforcement timing rather than to their own demand forecasts, a structural exposure with no near-term substitute feedstock route.

Late-2025 oversupply compressed producer pricing across major markets

Nicotinamide prices fell across all tracked regions in the third quarter of 2025, with US assessments down 9.14% quarter-on-quarter, Germany down 8.31%, and South Korea down 8.68%, as elevated importer inventories met weak nutraceutical and personal-care offtake. Distributors carrying inventory into the downturn absorbed the margin compression most directly, and the fragmented producer base left no single supplier able to hold price.

Regional Analysis

North America is named among the market’s key growth regions, with the United States expanding at a 6.6% CAGR through 2035. Import prices rose 8.16% month-on-month in January 2026 as tighter Asia-origin offers and thin spot inventories pushed buyers to secure cargoes ahead of the spring wellness season. Assessments then climbed for four straight quarters to USD 6,706.67 per MT in Q2 2026, a 22.57% jump.

Europe’s demand floor is set by regulation rather than local production: Commission Implementing Regulation (EU) 2024/1194 renewed the feed-grade niacinamide authorisation (3a315) until 15 May 2034, fixing a 99% purity floor for premix formulators. German assessments rose 21.98% QoQ in Q2 2026 to USD 6,678.33 per MT as Chinese export offers firmed, while the United Kingdom and Germany post country CAGRs of 8.2% and 7.4% respectively through 2035.

Asia Pacific carries the fastest national growth: India at a 10.5% CAGR, ahead of China at 9.7% and Japan at 8.9%. Jubilant Ingrevia’s Bharuch line added 5,000 tonnes per year of cGMP niacinamide capacity for food, cosmetic and infant-nutrition grades, yet ran at only about 50% of nameplate 18 months after commissioning. Chinese export availability tightened further in Q2 2026 after environmental inspections, lifting Chinese and Indian price assessments 21.74% and 15.6% QoQ.

Brazil absorbed 4.31% of China’s 2023 exports under HS 293629, the vitamin-derivative heading nicotinamide trades under, with Chile named alongside it as the region’s other tracked market. Import dependence on Chinese material leaves Brazilian and Chilean formulators exposed to the same export-availability swings that lifted North American and European landed costs through Q2 2026.

Coverage across the Kingdom of Saudi Arabia, other GCC states, Turkey and South Africa points to import-led formulation rather than domestic vitamin B3 synthesis, positioning the region as a downstream buyer of the same Chinese-origin material that set European and North American pricing through 2026.

Segment Analysis

By End Use Application

• Skin Care (largest, 10.4% share) – Facial and body skincare formulations such as serums, creams, and brightening treatments that use nicotinamide (vitamin B3) to support skin barrier function and even tone

• Facial Creams & Moisturizers
• Serums & Essences
• Facial Cleansers
• Toners
• Masks
• Body Care – Lotions, moisturizers, and body washes containing nicotinamide to hydrate skin and support overall body skin health beyond the face

• Body Lotions & Creams
• Body Washes & Cleansers
• Body Oils
• Hand & Foot Care
• Hair Care – Shampoos, conditioners, and scalp treatments that incorporate nicotinamide to support scalp condition and hair strand health

• Shampoos
• Conditioners
• Hair Serums & Oils
• Scalp Treatments
• Sun Care – Sunscreens and after-sun products that include nicotinamide alongside UV filters to support skin recovery from sun exposure

• Sunscreens
• After-Sun Care
• Self-Tanning Products
• Color Cosmetics – Makeup products such as foundations, primers, and concealers formulated with nicotinamide as a functional skin-benefit ingredient

• Foundations & BB/CC Creams
• Concealers
• Lip Products
• Eye Makeup
• Men’s Grooming – Shaving, post-shave, and facial care products marketed to men that use nicotinamide to soothe and condition skin

• Shaving Care
• Facial Care
• Beard Care
• Baby & Kids Care – Gentle skincare products formulated for infants and children, using nicotinamide for mild, low-irritation skin conditioning

• Baby Lotions & Creams
• Baby Cleansers
• Diaper Care
• Dermocosmetic / Professional Care – Pharmacy-distributed or clinician-recommended skincare formulations containing nicotinamide, often positioned between cosmetics and dermatological treatment

• Anti-Aging Treatments
• Skin Brightening & Pigmentation Care
• Acne & Blemish Treatments
• Barrier Repair Formulations

Skin Care leads End Use Application with a 10.4% share in 2025. Nicotinamide’s support for skin-barrier function and even tone lets formulators anchor serums, moisturizers and brightening treatments across both mass and dermocosmetic price tiers with a single label claim. Dermocosmetic and professional-care lines are the clearest growth line beyond that base, as brands reposition niacinamide from a general moisturizer into barrier-repair and pigmentation claims carried through pharmacy and clinician distribution.

By Product Form

• Powder – A dry, finely milled crystalline form of nicotinamide packaged as loose free-flowing particles, commonly blended directly into tablets, capsules, animal feed premixes, and food formulations

• Crystalline Powder
• Micronized Powder
• Spray-Dried Powder
• Coated Powder
• Granules / Agglomerates – Powder particles bound or compacted into larger free-flowing clusters, designed to reduce dust and improve flow and metering in industrial mixing and tableting lines

• Coated Granules
• Uncoated Granules
• Instant Granules
• Flakes – A flattened, plate-like solid form produced by cooling and breaking molten or crystallized nicotinamide into thin fragments for easier handling and dissolution

• Standard Flakes
• Micronized Flakes
• Pellets / Prills – Small, rounded solid units formed by spraying or extruding molten nicotinamide into uniform beads, used where controlled dosing and low dust generation are needed

• Coated Pellets
• Uncoated Pellets
• Liquid (Solution) – Nicotinamide fully dissolved in water or another solvent at a defined concentration, supplied ready for direct incorporation into beverages, injectables, or liquid feed

• Aqueous Solution
• Injectable Solution
• Oral Solution
• Concentrate (High-active Liquid) – A liquid preparation carrying a higher-than-standard load of dissolved nicotinamide, intended to be diluted by the end user before final application

• Feed-Grade Concentrate
• Premix Concentrate
• Dispersion / Suspension – A liquid carrier in which solid nicotinamide particles remain distributed rather than dissolved, used in formulations requiring the compound to stay suspended until use

• Aqueous Dispersion
• Oil-Based Suspension
• Emulsion – A two-phase liquid system in which nicotinamide is stabilized within an oil-and-water mixture using emulsifiers, applied in topical and cosmetic formulations

• Oil-in-Water Emulsion
• Water-in-Oil Emulsion

• Paste – A thick, semi-solid blend of nicotinamide with a carrier medium, formulated for applications such as topical treatments or feed supplementation requiring easy metering
• Gel – A semi-solid, cross-linked formulation containing nicotinamide within a gelling agent matrix, primarily used in skincare and topical pharmaceutical products

• Hydrogel
• Emulgel
• Wax / Solid Block – Nicotinamide combined with or formed into a solid waxy block or bar format, used in specialty industrial or personal-care applications requiring a molded solid carrier

• Slabs
• Molded Blocks
• Pastilles/Pellets
• Oil – An oil-based carrier formulation containing nicotinamide, used mainly in cosmetic and personal-care products where an oil-soluble or oil-dispersed delivery format is required

• Crude Oil
• Refined Oil

Powder is the conventional leading form across the broader vitamin B3 supply chain, chosen for ease of incorporation into tablet, premix and cosmetic blends and for cheaper transport than liquid formats. That handling advantage keeps crystalline and micronized powder the default intake form between blenders and brand-owners. Liquid, gel and emulsion formats are absorbing more new formulation work at the finishing end, pulled by cosmetic brands building niacinamide into serums and hydrogels as an oil-dispersed active rather than a bulk fortificant.

By Grade

• Pharmaceutical / USP Grade (largest) – Nicotinamide purified to United States Pharmacopeia specifications for use as a vitamin B3 active ingredient in tablets, injectables, and dietary supplements

• USP Grade
• BP/EP Grade
• JP Grade
• Cosmetic Grade – Nicotinamide formulated for topical application, incorporated into serums, moisturizers, and skincare products as niacinamide

• Standard Powder Grade
• Micronized (Ultra-fine) Grade
• Food Grade – Nicotinamide meeting food safety standards for use as a vitamin fortificant added to cereals, beverages, and nutritional products

• FCC Grade
• JECFA Grade
• Feed Grade – Nicotinamide produced for incorporation into animal feed formulations to supply vitamin B3 in livestock, poultry, and aquaculture nutrition

• Powder Grade
• Coated/Granular Grade
• Industrial / Technical Grade – Nicotinamide manufactured without pharmacopeial purity requirements for use as a chemical intermediate or additive in non-consumable industrial processes

• Electroplating Grade
• Textile Grade
• Plastic & Polymer Additive Grade

Pharmaceutical and USP grade leads the grade split, since dietary-supplement and drug-formulation buyers specify pharmacopeial purity that cosmetic or feed-grade material cannot substitute for. That purity threshold, not price, is what keeps pharma-grade volume distinct from the cosmetic and food streams even where the underlying molecule is identical. Feed grade holds a structurally protected base: Commission Implementing Regulation (EU) 2024/1194 fixes a 99% purity floor for the feed additive authorisation running to 15 May 2034, locking in premix demand independent of consumer trends. Cosmetic grade tracks the brightening and barrier-repair claims driving the End Use Application segment.

Country Growth Comparison

Country	CAGR (2025-2035)
India	10.5%
China	9.7%
Japan	8.9%
United Kingdom	8.2%
Germany	7.4%
United States	6.6%

The country CAGRs span 3.9 percentage points, from India at 10.5% to United States at 6.6%.

Competitive Landscape

The nicotinamide market is fragmented, and position is set less by capacity than by formulation know-how and specification lock-in. Suppliers compete on additive-package IP, pharmacopeial and REACH/TSCA compliance, technical service to formulators, and depth of distributor and OEM relationships; commodity feed and technical grades trade largely on price, while pharmaceutical, food and cosmetic grades compete on specification approval and purity certification. The market is led by a group of established specialty and diversified chemicals suppliers: BASF SE, Croda International, Evonik Industries, Symrise, Dow Inc., Ashland, Clariant, Seppic, Lubrizol, Lonza Group and Inolex, spanning integrated majors with backward feedstock positions and niche specialists selling into narrower cosmetic or pharmaceutical channels. Clariant completed a CHF 100 million capacity expansion at its Daya Bay, China site in October 2025, brought a second production line online in November 2025, and launched new specification-approved grades at K 2025, a pace of reinvestment that diversified suppliers across this competitor set can direct toward specialty-grade production more broadly.

Strategic Outlook

The clearest whitespace sits in dermocosmetic and professional-care skin formulations, where pharmacy-channel brands can extend niacinamide beyond general moisturizing into barrier-repair and pigmentation claims. Realizing it depends on cosmetic-grade supply holding steady while Chinese export tightening keeps landed costs elevated.

By 2035, competitive weight should tilt further toward specification-locked pharmaceutical and cosmetic grades over commodity feed and technical material, as buyers price Chinese export volatility into procurement as a structural cost rather than a temporary shock, and grade-specific purity requirements do more to sort suppliers than headline capacity.

Nicotinamide Market Report Scope

Attribute	Detail
Market Size 2025	253.20 (USD Million)
Market Size 2035	535.50 (USD Million)
Compound Annual Growth Rate (CAGR)	7.78% (2026 to 2035)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Segment Analysis and Trends
Base Year	2025
Market Forecast Period	2026 – 2035
Historical Data	2020 – 2025
Market Forecast Units	USD Million
Key Companies Profiled	BASF SE (DE); Croda International (GB); Evonik Industries (DE); Symrise (DE); Dow Inc. (US); Ashland (US); Clariant (CH); Seppic (FR); Lubrizol (US); Lonza Group (CH); Inolex (US)
Segments Covered	By End Use Application, By Product Form, By Grade
Key Market Opportunities	Formulators supplying feed-grade premixes have room to lock in long-term China offtake contracts before export-availability tightening pushes European buyers toward alternate sourcing.
Key Market Dynamics	Chinese export offer volumes, not regional production capacity, are now the swing factor setting nicotinamide prices in importing markets.
Regions Covered	North America, Europe, Asia Pacific, Middle East & Africa, Latin America

Market Insights

Frequently Asked Questions

Find answers to key questions about the Nicotinamide Market, including market size, growth outlook, regional trends, leading segments, growth drivers, key players, and environmental regulations.

01 How big is the Nicotinamide Market?

The Nicotinamide Market was valued at USD 253.2 Million in 2025. That base-year figure covers global demand across pharmaceutical, cosmetic, food, feed and industrial grades, spanning powder, granule, flake, pellet, liquid and gel product forms sold into skin care, body care, hair care and dermocosmetic formulations worldwide.

02 What is the growth forecast for the Nicotinamide Market?

The Nicotinamide Market is projected to reach USD 535.5 Million by 2035, up from USD 253.2 Million in 2025, at a 7.78% CAGR across 2025-2035. That trajectory more than doubles the base-year value over the ten-year forecast window, reflecting steady offtake growth across cosmetic and pharmaceutical grade demand.

03 Which region holds the largest share of the Nicotinamide Market?

Asia Pacific anchors global nicotinamide supply, led by China, which exported USD 421 Million of vitamin derivatives under HS code 293629 in 2023, more than four times the value shipped to the next-largest destination, the United States, at USD 115 Million.

04 Which region is growing fastest in the Nicotinamide Market?

Asia Pacific is expanding fastest, led by India at a 10.5% CAGR through 2035, the highest of any country tracked, ahead of China at 9.7% and Japan at 8.9%. All three rank among the fastest-growing markets tracked, positioning Asia Pacific as the lead growth region overall.

05 Which segment leads the Nicotinamide Market?

Skin Care leads the Nicotinamide Market with a 10.4% share of end-use application demand, driven by facial serums, moisturizers, and brightening treatments that use nicotinamide to support skin barrier function and even tone. Body care and dermocosmetic care follow as adjacent categories.

06 What is driving growth in the Nicotinamide Market?

Formulation expansion into dermocosmetic and skin-brightening treatments is a primary driver of the Nicotinamide Market, alongside secured regulatory status such as the EU’s renewal of feed-grade authorization under Regulation (EU) 2024/1194, valid through 15 May 2034. Both support steady offtake across cosmetic and feed channels.

07 Who are the key players in the Nicotinamide Market?

BASF SE, Croda International, Evonik Industries, Symrise, Dow Inc., Ashland, Clariant, and Lonza Group are among the key players in the Nicotinamide Market. These companies span integrated chemical majors and specialty ingredient suppliers serving pharmaceutical, cosmetic, food and feed grade demand.

08 How are environmental regulations affecting the Nicotinamide Market?

Chinese environmental inspections tightened nicotinamide export availability in Q2 2026, pushing China’s price assessment up 21.74% quarter-on-quarter and India’s up 15.6%. In the EU, feed-grade use remains tied to Regulation (EU) 2024/1194, which requires 99% minimum purity through its 2034 renewal.